ConductScience.org, home

Trial · NCT01101022

Outcomes15

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline in Subject-reported Behavior Rating Inventory of Executive Function - Adult Version Global Executive Composite T-score (BRIEF-A GEC T) at up to 10 WeeksBaseline and up to 10 weeksFull Analysis Set (FAS) defined as all subjects who took 1 dose of investigational product in the double-blind evaluation phase and had 1 primary efficacy assessment.T-scoresLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Adult ADHD Impact Module (AIM-A) Multi-Item Scales Total Score at up to 10 WeeksBaseline and up to 10 weeksFASScores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Informant-reported BRIEF-A T-scores at up to 10 WeeksBaseline and up to10 weeksFAST-scoresLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Subject-reported BRIEF-A T-scores at up to 10 WeeksBaseline and up to 10 weeksFAST-scoresMEAN
SECONDARYChange From Baseline in Subject-reported BRIEF-A Clinical Subscales T-scores at up to 10 WeeksBaseline and up to 10 weeksFAST-scoresLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Informant-reported BRIEF-A Clinical Subscales T-scores at up to 10 WeeksBaseline and up to 10 weeksFAST-scoresLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS) With Adult Prompts Total Score at up to 10 WeeksBaseline and up to 10 weeksFASScores on a scaleLEAST_SQUARES_MEAN
SECONDARYPercent of Participants With Clinical Global Impression - Severity of Illness (CGI-S) at BaselineBaselineFASPercent of participantsNUMBER
SECONDARYPercent of Participants With Clinical Global Impression - Severity of Illness (CGI-S) at up to 10 WeeksUp to 10 weeks post-doseFASPercent of participantsNUMBER
SECONDARYPercent of Participants With Improvement on Clinical Global Impression - Global Improvement (CGI-I) at up to 10 WeeksUp to 10 weeks post-doseFASPercent of participantsNUMBER
SECONDARYChange From Baseline in AIM-A Multi-Item Scales of Living With ADHD and General Well-being Score at up to 10 WeeksBaseline and up to 10 weeksFASScores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in AIM-A Quality of Life Questions 1 and 4 Scores at up to 10 WeeksBaseline and up to 10 weeksFASScores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Conner's Adult ADHD Rating Scale-Observer: Short Version (CAARS-O:S) ADHD Index T-score at up to 10 WeeksBaseline and up to 10 weeksFAST-scoresLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in CAARS-O:S Factor-derived Subscale T-scores at up to 10 WeeksBaseline and up to 10 weeksFAST-scoresLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Adult ADHD Quality of Life (AAQoL) Scale Total Score at up to 10 WeeksBaseline and up to 10 weeksFASScores on a scaleLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01101022/outcomes